Ma D - Search Results

1

A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation.

Chiu D, Tavaré R, Haber L, Aina OH, Vazzana K, Ram P, Danton M, Finney J, Jalal S, Krueger P, Giurleo JT, Ma D, Smith E, Thurston G, Kirshner JR, Crawford A. Chiu D, et al. Among authors: ma d. Cancer Immunol Res. 2020 May;8(5):596-608. doi: 10.1158/2326-6066.CIR-19-0518. Epub 2020 Mar 17. Cancer Immunol Res. 2020. PMID: 32184296

2

Potent antitumor activity of an auristatin-conjugated, fully human monoclonal antibody to prostate-specific membrane antigen.

Ma D, Hopf CE, Malewicz AD, Donovan GP, Senter PD, Goeckeler WF, Maddon PJ, Olson WC. Ma D, et al. Clin Cancer Res. 2006 Apr 15;12(8):2591-6. doi: 10.1158/1078-0432.CCR-05-2107. Clin Cancer Res. 2006. PMID: 16638870

3

Preclinical PET imaging with the novel human antibody ⁸⁹Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues.

Kelly MP, Makonnen S, Hickey C, Arnold TC, Giurleo JT, Tavaré R, Danton M, Granados C, Chatterjee I, Dudgeon D, Retter MW, Ma D, Olson WC, Thurston G, Kirshner JR. Kelly MP, et al. Among authors: ma d. J Immunother Cancer. 2021 Jan;9(1):e002025. doi: 10.1136/jitc-2020-002025. J Immunother Cancer. 2021. PMID: 33483343 Free PMC article.

4

Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054.

Tavaré R, Danton M, Giurleo JT, Makonnen S, Hickey C, Arnold TC, Kelly MP, Fredriksson F, Bruestle K, Hermann A, Ullman E, Edelmann KH, Potocky T, Dudgeon D, Bhatt NB, Doubrovin M, Barry T, Kyratsous CA, Gurer C, Tu N, Gartner H, Murphy A, Macdonald LE, Popke J, Mintz A, Griesemer A, Olson WC, Thurston G, Ma D, Kirshner JR. Tavaré R, et al. Among authors: ma d. Cancer Immunol Res. 2022 Oct 4;10(10):1190-1209. doi: 10.1158/2326-6066.CIR-21-0405. Cancer Immunol Res. 2022. PMID: 35895745 Free PMC article.

5

A Bispecific METxMET Antibody-Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes.

Perez Bay AE, Faulkner D, DaSilva JO, Young TM, Yang K, Giurleo JT, Ma D, Delfino FJ, Olson WC, Thurston G, Daly C, Andreev J. Perez Bay AE, et al. Among authors: ma d. Mol Cancer Ther. 2023 Mar 2;22(3):357-370. doi: 10.1158/1535-7163.MCT-22-0414. Mol Cancer Ther. 2023. PMID: 36861363 Free PMC article.

6

The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.

Schülke N, Varlamova OA, Donovan GP, Ma D, Gardner JP, Morrissey DM, Arrigale RR, Zhan C, Chodera AJ, Surowitz KG, Maddon PJ, Heston WD, Olson WC. Schülke N, et al. Among authors: ma d. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12590-5. doi: 10.1073/pnas.1735443100. Proc Natl Acad Sci U S A. 2003. PMID: 14583590 Free PMC article.

7

In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen.

Wang X, Ma D, Olson WC, Heston WD. Wang X, et al. Among authors: ma d. Mol Cancer Ther. 2011 Sep;10(9):1728-39. doi: 10.1158/1535-7163.MCT-11-0191. Epub 2011 Jul 12. Mol Cancer Ther. 2011. PMID: 21750220

8

Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1.

Betts A, Clark T, Jasper P, Tolsma J, van der Graaf PH, Graziani EI, Rosfjord E, Sung M, Ma D, Barletta F. Betts A, et al. Among authors: ma d. J Pharmacokinet Pharmacodyn. 2020 Oct;47(5):513-526. doi: 10.1007/s10928-020-09702-3. Epub 2020 Jul 24. J Pharmacokinet Pharmacodyn. 2020. PMID: 32710210 Free PMC article.

9

Multiplex Immuno-Liquid Chromatography-Mass Spectrometry-Parallel Reaction Monitoring (LC-MS-PRM) Quantitation of CD8A, CD4, LAG3, PD1, PD-L1, and PD-L2 in Frozen Human Tissues.

Zhang Q, Salzler R, Dore A, Yang J, Ma D, Olson WC, Liu Y. Zhang Q, et al. Among authors: ma d. J Proteome Res. 2018 Nov 2;17(11):3932-3940. doi: 10.1021/acs.jproteome.8b00605. Epub 2018 Oct 11. J Proteome Res. 2018. PMID: 30277784

10

PF-06804103, A Site-specific Anti-HER2 Antibody-Drug Conjugate for the Treatment of HER2-expressing Breast, Gastric, and Lung Cancers.

Graziani EI, Sung M, Ma D, Narayanan B, Marquette K, Puthenveetil S, Tumey LN, Bikker J, Casavant J, Bennett EM, Charati MB, Golas J, Hosselet C, Rohde CM, Hu G, Guffroy M, Falahatpisheh H, Finkelstein M, Clark T, Barletta F, Tchistiakova L, Lucas J, Rosfjord E, Loganzo F, O'Donnell CJ, Gerber HP, Sapra P. Graziani EI, et al. Among authors: ma d. Mol Cancer Ther. 2020 Oct;19(10):2068-2078. doi: 10.1158/1535-7163.MCT-20-0237. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747418

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,753 results

Search Page

Filters